As our health care payment and delivery systems shift from volume-based to value-based care, quality measures play a critical role in making this a successful transition. That’s why getting quality measures right—and conversations like those happening at this week’s Pharmaceutical Quality Alliance’s (PQA) 2016 Annual Meeting—is so important.
This year’s PQA Annual Meeting, which the National Pharmaceutical Council (NPC) is cosponsoring, will gather leaders from all stakeholder communities to discuss the state of the industry and share ideas on how to improve medication use and safety in keeping with the shift toward value-based care.
These dialogues about the current state of quality measures and how they can be improved are yet another example of how stakeholders are working together to navigate the new value-based system while ensuring patient safety and high-quality care.
NPC has long examined quality measures in an effort to move the conversation forward and address existing challenges, including: ways to better incorporate the patient’s voice and experience in quality measure development; how to account for differences across patient groups; and what steps will help in moving beyond “box-checking” to meaningful measures that positively impact patient care.
In fact, NPC has researched multiple issues related to quality in recent years by:
- Convening thought leaders and patient groups for a real conversation about how to advance the use of quality measurement in accountable care systems;
- Identifying ways to address the gaps in quality measurement that currently exist and include the patient community in their development; and
- Creating an interactive two-part continuing education series that includes the basics of quality measurement and what those in the biopharmaceutical industry need to know about quality measurement.
As quality measures evolve, they will likely play an even larger role in a value-based health system. The discussions such as those that will take place at PQA’s Annual Meeting are important because they provide a forum for all stakeholders to come together and engage in open dialogue to work on improving quality measures, address the gaps that exist, and better engage the patient community in the quality measures discussion.